ResMed SG&A Expense (Quarterly) Analysis

ResMed Inc (RMD)

212.90 -3.26 (-1.51%) USD | NYSE | May 08, 16:00

212.87 -0.02 (-0.01%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.

Date	Value
March 31, 2024	229.92M
December 31, 2023	222.16M
September 30, 2023	222.87M
June 30, 2023	240.69M
March 31, 2023	228.46M
December 31, 2022	211.67M
September 30, 2022	193.93M
June 30, 2022	193.02M
March 31, 2022	182.40M
December 31, 2021	185.36M
September 30, 2021	176.72M
June 30, 2021	181.48M
March 31, 2021	160.45M
December 31, 2020	169.47M
September 30, 2020	158.99M
June 30, 2020	165.38M
March 31, 2020	172.44M
December 31, 2019	171.42M
September 30, 2019	167.44M
June 30, 2019	171.60M
March 31, 2019	164.53M
December 31, 2018	161.58M
September 30, 2018	147.30M
June 30, 2018	156.81M
March 31, 2018	147.89M

Date	Value
December 31, 2017	151.82M
September 30, 2017	143.85M
June 30, 2017	147.94M
March 31, 2017	137.86M
December 31, 2016	139.31M
September 30, 2016	128.85M
June 30, 2016	135.84M
March 31, 2016	122.90M
December 31, 2015	118.22M
September 30, 2015	111.10M
June 30, 2015	129.25M
March 31, 2015	116.34M
December 31, 2014	122.52M
September 30, 2014	110.52M
June 30, 2014	122.24M
March 31, 2014	115.10M
December 31, 2013	111.75M
September 30, 2013	101.32M
June 30, 2013	115.06M
March 31, 2013	109.63M
December 31, 2012	107.82M
September 30, 2012	98.30M
June 30, 2012	105.91M
March 31, 2012	101.96M
December 31, 2011	100.55M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

158.99M

Minimum

Sep 2020

240.69M

Maximum

Jun 2023

190.29M

Average

181.94M

Median

SG&A Expense (Quarterly) Benchmarks